A Study to Learn More About the Safety and the Level of BAY 1747846 in Body Given as Injection Into the Vein at Increasing Single Doses in Japanese Healthy Male Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

April 17, 2019

Primary Completion Date

June 19, 2019

Study Completion Date

July 11, 2019

Conditions
Contrast Enhancement in Magnetic Resonance ImagingHealthy Volunteers
Interventions
DRUG

BAY1747846

Single dose; IV injection.

DRUG

Matching placebo

Single dose; IV injection.

Trial Locations (1)

813-0017

SOUSEIKAI Fukuoka Mirai Hospital, Fukuoka

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Bayer

INDUSTRY